Practical considerations in starting a peripheral lymphedema magnetic resonance imaging program

Abstract

The management of chronic peripheral lymphedema benefits from a multidisciplinary approach in which magnetic resonance imaging (MRI) can play a key role. The imaging has been well described in the literature (including this journal), but the process for starting a novel imaging service line is complex. Participants in this process, including radiologists, imaging technical staff, information technologists, and revenue cycle managers, must be engaged and work in harmony to achieve success. The purpose of this article is to detail the building blocks and steps in starting a peripheral lymphedema MRI program, how our process evolved, and lessons learned along the way.

Keywords

Magnetic resonance lymphangiography / magnetic resonance lymphography / lymphedema / radiology service line

References

[1] Warren AG,Borud LJ.Lymphedema: a comprehensive review.Ann Plast Surg2007;59:464-72

[2] Mihara M,Hayashi Y.Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic vessels after lymphadenectomy.PLoS One2012;7:e41126 PMCID:PMC3404077

[3] Yamamoto T,Yoshimatsu H,Koshima I.Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels.Plast Reconstr Surg2017;140:734-41

[4] Granzow JW,Kaji AH.Review of current surgical treatments for lymphedema.Ann Surg Oncol2014;21:1195-201

[5] Calderwood A,Ho-shon K.Overview of magnetic resonance lymphography for imaging lymphoedema.PAR2021;

[6] Yang JC,Chiang MH.Targeting reflux-free veins with a vein visualizer to identify the ideal recipient vein preoperatively for optimal lymphaticovenous anastomosis in treating lymphedema.Plast Reconstr Surg2018;141:793-7

[7] Seki Y,Asai R.Functional lymphaticovenular anastomosis for peripheral lymphedema: incision selection methods with muscle pumping.PAR2021;

[8] Garza RM,Chang DW.Physical and functional outcomes of simultaneous vascularized lymph node transplant and lymphovenous bypass in the treatment of lymphedema.Plast Reconstr Surg2022;150:169-80

[9] Mitsumori LM,Neligan PC.Peripheral magnetic resonance lymphangiography: techniques and applications.Tech Vasc Interv Radiol2016;19:262-72

[10] Mazzei FG,Guerrini S.MR lymphangiography: a practical guide to perform it and a brief review of the literature from a technical point of view.Biomed Res Int2017;2017:2598358 PMCID:PMC5359436

[11] Hawkins CM.Building a radiology service line: key elements and necessary actions.Curr Probl Diagn Radiol2016;45:107-10

[12] Guerrini S,Mazzei FG,Volterrani L.Magnetic resonance lymphangiography: with or without contrast?.Diagn Interv Radiol2020;26:587-95 PMCID:PMC7664753

[13] Chan S.The importance of strategy for the evolving field of radiology.Radiology2002;224:639-48

[14] White RD,Budak MJ,Munnoch DA.Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema.Clin Radiol2014;69:e435-44

[15] Notohamiprodjo M,Jakobs TF.MR-lymphangiography at 3.0 T - a feasibility study.Eur Radiol2009;19:2771-8

[16] Ripley B,Lalwani N,Neligan PC.Initial clinical experience with dual-agent relaxation contrast for isolated lymphatic channel Mapping.Radiology2018;286:705-14

[17] Maki JH,Briller N,Wilson GJ.Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents.Curr Probl Diagn Radiol2016;45:174-9

[18] U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warnings-and-changes-prescribing-instructions-decrease [Last accessed on 29 Jul 2022]